Complications of Covid-19 on the Central Nervous System

Tabatabaeifar, Seyed Mahmoud; Seddighi, Afsoun; Seddighi, Amir Saied; Ghadirian, Mahsa

doi:10.22034/6.1.25

[Home ] [Archive]

[ فارسی ]

Iranian Journal of Culture and Health Promotion

Main Menu

Home

Journal Information

Articles archive

For Authors

For Reviewers

Registration

Publication Ethics

Contact us

Site Facilities

ISSN

p-ISSN: 2645-8233
e-ISSN: 2645-5943

Search in website

Receive site information

Volume 6, Issue 1 (Spring 2022)

Iran J Cult Health Promot 2022, 6(1): 191-197

Back to browse issues page

Complications of Covid-19 on the Central Nervous System

Seyed Mahmoud Tabatabaeifar

, Afsoun Seddighi

, Amir Saied Seddighi

, Mahsa Ghadirian

Functional Neurosurgical Research Center of Shohada Tajrish Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran

Abstract: (2973 Views)

Background: The newfound coronavirus epidemic first broke out in China and soon spread in the world and became a global issue. WHO named it "Covid-19 Syndrome”. Multisystemic involvement and viral inflammation by a virus with more than 3,853 genomes exacerbated the deteriorating situation by the day and led the thought to study its inflammatory effects on other organs. In this article, the effects of Covid 19 on the central nervous system are investigated.
Methods: This study was performed by reviewing the referrences and documents which reported the effects of this disease on the central nervous system.
Results: Contemplation of the potential effects of the Covid-19 virus on the brain and in general on the CNS consist a range of or related brain injuries including hemorrhagic lesions, vascular thrombosis, inflammatory lesions of the glial tissue of the brain, brain syndromes, and a variety of neurologic manifestations brought to mind, in which the thalamus and brainstem were considered as sensitive areas to be directly attacked by the virus, and imaging findings revealed these attacks as well. Cytokine storm and the role of ACE2 as the most well-known receptor in cell binding through which viral degradation occurs can be considered as a precursor of the systemic invasion of coronavirus. Although intracranial hemorrhages have major risks to the central nervous system in the Covid-19 pandemic, it should be noted that they are rare phenomena as having been reported in less than one percent of reports mostly were case-report ,therefore it can be said that the role of Covid-19 in causing cerebral hemorrhage cannot be proved.
Conclusion: Obviously, in Covid-19, it is important to choose the appropriate surgical protocols and consider safety points. The decision to perform the surgeries should be made with full knowledge of the risks.

Keywords: Angiotensin-Converting Enzyme2, Blood Coagulation Disorders, Central Nervous System, COVID-19, Intracranial Hemorrhages

Full-Text [PDF 242 kb] (720 Downloads)

Letter: Review Article | Subject: Special
Received: 2022/05/19 | Accepted: 2022/05/25 | ePublished ahead of print: 2022/06/10 | Published: 2022/06/21

References

1. 1. Andersen KG, Rambaut A, Lipkin WI, Holmes EC, Garry RF. The proximal origin of SARS-CoV-2. Nat Med 2020 Apr; 26(4): 450-452.

2. 2. She J, Jiang J, Ye L, Hu L, Bai C, Song Y. 2019 novel coronavirus of pneumonia in Wuhan, China: emerging attack and management strategies. Clin Transl Med 2020 Feb 20; 9(1): 19.

3. 3. Huang Y, Yang C, Xu XF, Xu W, Liu SW. Structural and functional properties of SARS-CoV-2 spike protein: potential antivirus drug development for COVID-19. Acta Pharmacol Sin 2020 Sep; 41(9): 1141-1149.

4. 4. Shang J, Ye G, Shi K, Wan Y, Luo C, Aihara H, et al. Structural basis of receptor recognition by SARS-CoV-2. Nature 2020 May; 581(7807): 221-224.

5. 5. Heaton NS. Revisiting the concept of a cytopathic viral infection. PLoS Pathog 2017 Jul 20; 13(7): e1006409.

6. 6. Dhar Chowdhury S, Oommen AM. Epidemiology of COVID-19. Journal of Digestive Endoscopy 2020 Mar; 11(1): 3–7.

7. 7. Wu Y, Xu X, Chen Z, Duan J, Hashimoto K, Yang L, et al. Nervous system involvement after infection with COVID-19 and other coronaviruses. Brain Behav Immun 2020 Jul; 87: 18-22.

8. 8. Asadi-Pooya AA, Simani L. Central nervous system manifestations of COVID-19: A systematic review. J Neurol Sci 2020 Jun 15; 413: 116832.

9. 9. Garg R, Jain R, Sodani A, Chouksey D, Dosi R, Athale S, et al. Neurological Symptoms as Initial Manifestation of Covid-19 - An Observational Study. Ann Indian Acad Neurol 2020; 23(4): 482-486.

10. 10. Kikuta S, Matsumoto Y, Kuboki A, Nakayama T, Asaka D, Otori N, et al. Longer latency of sensory response to intravenous odor injection predicts olfactory neural disorder. Sci Rep 2016 Oct 13; 6: 35361.

11. 11. Izquierdo-Domínguez A, Rojas-Lechuga MJ, Mullol J, Alobid I. Olfactory dysfunction during COVID-19 pandemic. Med Clin (Barc) 2020 Nov 13; 155(9): 403-408.

12. 12. Afari N, Buchwald D. Chronic fatigue syndrome: a review. Am J Psychiatry 2003 Feb; 160(2): 221-36.

13. 13. Ahmed MU, Hanif M, Ali MJ, Haider MA, Kherani D, Memon GM, et al. Neurological Manifestations of COVID-19 (SARS-CoV-2): A Review. Front Neurol 2020 May 22; 11: 518.

14. 14. Bushra JS. Miller Fisher syndrome: an uncommon acute neuropathy. J Emerg Med 2000 May; 18(4): 427-30.

15. 15. Pearce JM. Wallenberg's syndrome. J Neurol Neurosurg Psychiatry 2000 May; 68(5): 570.

16. 16. Van Beusekom M. Study: 80% of hospital COVID-19 patients have neurologic complications. 2021. CIDRAP News. Available at: https://www.cidrap.umn.edu/news-perspective/2021/05/study-80-hospital-covid-19-patients-have-neurologic-complications

17. 17. Song P, Li W, Xie J, Hou Y, You C. Cytokine storm induced by SARS-CoV-2. Clin Chim Acta 2020 Oct; 509: 280-287.

18. 18. Kang S, Kishimoto T. Interplay between interleukin-6 signaling and the vascular endothelium in cytokine storms. Exp Mol Med 2021 Jul; 53(7): 1116-1123.

19. 19. Freitas-Rodríguez S, Folgueras AR, López-Otín C. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond. Biochim Biophys Acta Mol Cell Res 2017 Nov; 1864(11 Pt A): 2015-2025.

20. 20. Nagel MA, Jones D, Wyborny A. Varicella zoster virus vasculopathy: The expanding clinical spectrum and pathogenesis. J Neuroimmunol 2017 Jul 15; 308: 112-117.

21. 21. Bosso M, Thanaraj TA, Abu-Farha M, Alanbaei M, Abubaker J, Al-Mulla F. The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19. Mol Ther Methods Clin Dev 2020 Jun 25; 18: 321-327.

22. 22. Chigr F, Merzouki M, Najimi M. Autonomic Brain Centers and Pathophysiology of COVID-19. ACS Chem Neurosci 2020 Jun 3; 11(11): 1520-1522.

23. 23. Nitish M, Dhanya R, Janani V. Battling high blood pressure in the COVID-19 era. 2020. Covid Gyan. Available at: https://covid-gyan.in/article/battling-high-blood-pressure-covid-19-era

24. 24. Ghosh R, Roy D, Mandal A, Pal SK, Chandra Swaika B, Naga D, et al. Cerebral venous thrombosis in COVID-19. Diabetes Metab Syndr 2021 May-Jun; 15(3): 1039-1045.

25. 25. Costela-Ruiz VJ, Illescas-Montes R, Puerta-Puerta JM, Ruiz C, Melguizo-Rodríguez L. SARS-CoV-2 infection: The role of cytokines in COVID-19 disease. Cytokine Growth Factor Rev 2020 Aug; 54: 62-75.

26. 26. Rasa S, Nora-Krukle Z, Henning N, Eliassen E, Shikova E, Harrer T, et al. European Network on ME/CFS (EUROMENE). Chronic viral infections in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS). J Transl Med 2018 Oct 1; 16(1): 268.

27. 27. Qi X, Keith KA, Huang JH. COVID-19 and stroke: A review. Brain Hemorrhages 2021 Jun; 2(2): 76-83.

28. 28. Li Y, Li M, Wang M, Zhou Y, Chang J, Xian Y, et al. Acute cerebrovascular disease following COVID-19: a single center, retrospective, observational study. Stroke Vasc Neurol. 2020 Sep;5(3):279-284.

29. 29. Margos NP, Meintanopoulos AS, Filioglou D, Ellul J. Intracerebral hemorrhage in COVID-19: A narrative review. J Clin Neurosci 2021 Jul; 89: 271-278.

30. 30. Benger M, Williams O, Siddiqui J, Sztriha L. Intracerebral haemorrhage and COVID-19: Clinical characteristics from a case series. Brain Behav Immun 2020 Aug; 88: 940-944.

31. 31. Cheruiyot I, Sehmi P, Ominde B, Bundi P, Mislani M, Ngure B, et al. Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients. Neurol Sci 2021 Jan; 42(1): 25-33.

32. 32. Peckham H, de Gruijter NM, Raine C, Radziszewska A, Ciurtin C, Wedderburn LR, et al. Male sex identified by global COVID-19 meta-analysis as a risk factor for death and ITU admission. Nat Commun. 2020 Dec 9; 11(1): 6317.

33. 33. Melmed KR, Cao M, Dogra S, Zhang R, Yaghi S, Lewis A, et al. Risk factors for intracerebral hemorrhage in patients with COVID-19. J Thromb Thrombolysis. 2021 May;51(4):953-960.

34. 34. de Oliveira Manoel AL. Surgery for spontaneous intracerebral hemorrhage. Crit Care 2020 Feb 7; 24(1): 45.

35. 35. Babi MA, James ML. Spontaneous Intracerebral Hemorrhage: Should We Operate? Front Neurol 2017 Dec 4; 8: 645.

36. 36. Raffiq A, Seng LB, San LS, Zakaria Z, Yee AS, Fitzrol DN, et al. COVID-19 Pandemic and Its Impact on Neurosurgery Practice in Malaysia: Academic Insights, Clinical Experience and Protocols from March till August 2020. Malays J Med Sci 2020 Oct; 27(5): 141-195.

37. 37. Long H Nguyen, David A Drew, Mark S Graham, Amit D Joshi, Chuan-Guo Guo, MS Wenjie Ma, et al. Risk of COVID-19 among front-line health-care workers and the general community: a prospective cohort study. Lancet Public Health 2020 Sep; 5(9): e475-e483.

38. 38. Klompas M, Baker M, Rhee C. What Is an Aerosol-Generating Procedure? JAMA Surg 2021 Feb 1; 156(2): 113-114.

39. 39. Jain NS, Alluri RK, Schopler SS, Hah R, Wang JC. COVID-19 and Spine Surgery: A Review and Evolving Recommendations. Global Spine J 2020 Aug; 10(5): 528-533.

40. 40. Jackson T, Deibert D, Wyatt G, Durand-Moreau Q, Adisesh A, Khunti K. Classification of aerosol-generating procedures: a rapid systematic review. BMJ Open Respir Res 2020 Oct; 7(1): e000730.

41. 41. Thiagarajan S, Shetty P, Gulia A, Prakash G, Pramesh CS, Puri A. A Survey of Personnel Protective equipment's (PPE) Use and Comfort Levels Among Surgeons During Routine Cancer Surgery in the COVID-19 Pandemic. Indian J Surg Oncol 2021 Mar 26; 12(2): 1-9.

42. 42. Prin M, Bartels K. Social distancing: implications for the operating room in the face of COVID-19. Can J Anaesth 2020 Jul; 67(7): 789-797.

43. 43. Shah S, Gadiya A, Patel MS, Shafafy M. Coronavirus Disease 2019 Transmission: Blood Viremia and Aerosol Generation from Spinal Surgery. Is There an Increased Risk to the Surgical Team? Asian Spine J 2020 Oct; 14(5): 702-709.

44. 44. Iorio-Morin C, Hodaie M, Sarica C, Dea N, Westwick HJ, Christie SD, et al. Letter: The Risk of COVID-19 Infection During Neurosurgical Procedures: A Review of Severe Acute Respiratory Distress Syndrome Coronavirus 2 (SARS-CoV-2) Modes of Transmission and Proposed Neurosurgery-Specific Measures for Mitigation. Neurosurgery 2020 Aug 1; 87(2): E178-E185.

45. 45. Prakash L, Dhar SA, Mushtaq M. COVID-19 in the operating room: a review of evolving safety protocols. Patient Saf Surg 2020 Jul 20; 14:30.

46. 46. Shemshadi H, Layeghi F, Khorasani B. Elective Surgery Guidelines During COVID-19 Pandemic: A Current Literature Review. Health in Emergencies & Disasters Quarterly 2021; 6(2): 67-72.

47. 47. Louie PK, Harada GK, McCarthy MH, Germscheid N, Cheung JPY, Neva MH, et al. The Impact of COVID-19 Pandemic on Spine Surgeons Worldwide. Global Spine J 2020 Aug; 10(5): 534-552.

48. 48. Mowbray NG, Ansell J, Horwood J, Cornish J, Rizkallah P, Parker A, et al. Safe management of surgical smoke in the age of COVID-19. Br J Surg. 2020 Oct; 107(11): 1406-1413.

49. 49. Toombs CS, Boody BS, Bronson WH, Girasole GJ, Russo GS. Safe Spine Surgery During the COVID-19 Pandemic. Clin Spine Surg 2021 Apr 1; 34(3): 87-91.

50. 50. Wang TV, Ito M. Spine Surgery: Precautions and Strategies to Minimize Perioperative Risks Amid COVID-19 Outbreak. Spine Surg Relat Res 2020 Jun 3; 4(3): 192-198.

Send email to the article author

Add your comments about this article

‎ 10.22034/6.1.25

Mendeley

Zotero

RefWorks

Tabatabaeifar S M, Seddighi A, Seddighi A S, Ghadirian M. Complications of Covid-19 on the Central Nervous System. Iran J Cult Health Promot 2022; 6 (1) :191-197
URL: http://ijhp.ir/article-1-561-en.html

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Volume 6, Issue 1 (Spring 2022)

Back to browse issues page

Rights and permissions
	This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Persian site map - English site map - Created in 0.12 seconds with 39 queries by YEKTAWEB 4732